We supply research peptides that meet a standard most importers cannot match: synthesized in the United States, independently verified, and documented batch by batch.
The research peptide industry sells consistency in marketing copy and inconsistency in the vial. We built ChainNovaLabs to flip that equation.
The research peptide market is flooded with low-purity imports from opaque supply chains. Researchers receive vials with missing batch documentation, inconsistent identity, and no recourse when material fails analysis. We launched ChainNovaLabs to be the opposite of that supplier.
Every compound we sell is synthesized in a domestic United States laboratory. We do not source finished product from overseas and relabel it. We do not blend lower-cost imports into our catalog. The chemistry happens here, the quality control happens here, and the vials ship from here.
ChainNovaLabs sells exclusively to qualified researchers: academic labs, industry R&D groups, government research entities, and independent investigators who need consistent material for in-vitro work. We do not sell to consumers, and our products are not intended for human or veterinary use under any circumstances.
Our catalog will keep growing, but the quality bar is fixed. If a batch fails purity verification, it does not ship. If a compound cannot be sourced domestically at our standard, we do not carry it. That is the line.